DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE:ABBV) on 06/23/2022 declared a dividend of $1.4100 per share

AbbVie Inc (NYSE:ABBV) on 06/23/2022 declared a dividend of $ 1.4100 per share payable on August 15, 2022 to shareholders of record as of July 15, 2022.

AbbVie Inc (NYSE:ABBV) has paid dividends since 2013, has a current dividend yield of 3.8221740723% and has increased its dividends for 8 successive years.

AbbVie Inc's market cap is $ 260,754,751,600 and has a PE ratio of 21.17. The stock price closed yesterday at $ 147.56 and has a 52 week low/high of $ 105.56 and $ 175.91.

AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.

For more information on AbbVie Inc click here.